PET Imaging of a [(18)F]-radiolabeled PARP Inhibitor Monitors the Therapeutic Efficacy of Talazoparib in Small Cell Lung Cancer Patient-Derived Xenografts

INTRODUCTION: Inhibitors of poly-(ADP)-ribose polymerase (PARP) are promising therapeutics for small cell lung cancer (SCLC). We tested whether PARP inhibitor (PARPi) target engagement as measured by a radiolabeled PARP inhibitor ([(18)F]PARPi) has the potential to predict drug efficacy in vivo. MET...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Thorac Oncol
Auteurs principaux: Laird, James, Lok, Benjamin H., Carney, Brandon, Kossatz, Susanne, de Stanchina, Elisa, Reiner, Thomas, Poirier, John T., Rudin, Charles M.
Format: Artigo
Langue:Inglês
Publié: 2019
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6764879/
https://ncbi.nlm.nih.gov/pubmed/31195178
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtho.2019.05.032
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires